Clinical Trial Update: Evaluation on Immunogenicity and Safety Profile of Trivalent OPV (tOPV Bio Farma) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating immunogenicity and safety of Trivalent OPV (tOPV Bio Farma) in healthy participants. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Drugs mentioned

• Trivalent OPV (Oral poliovirus vaccine, trivalent)

Snippet

Sponsor: PT Bio Farma | Conditions: Healthy | Phase 2 | Status: COMPLETED